ST Muyao (600671): Special Explanation of the Board of Directors of Hangzhou Tianmushan Pharmaceutical Co., Ltd. on the Internal Control Audit Report Issued by the Accounting Firm CFi.CN Zhongcai.com

Key Data Concepts:   

? These are the company names, stock quotes, topics, and entities related to this data.

000063 300431 300568 300626 Baofeng Group China Shipbuilding Industry Group Power Citic Securities Dongfang Electric Corporation Fujian Funeng Hangzhou Tian-Mu-Shan Pharmaceutical Enterprise Huarui Electrical Appliance Shenzhen Senior Technology Material Xinjiang Sayram Modern Agriculture ZTE ZTE Corporation Arts, Culture, Entertainment, Media Crime, Law, Justice Culture Festive Event, Culture Television Court Litigation Prosecution Law Regulations Criminal Law Accounting, Audit Shareholder Management Strategy, Marketing Board Of Directors Research, Development Health, Beauty Product Pharmaceutical Construction, Property Design, Engineering Financial, Business Service Manufacturing, Engineering Pet Product, Service Economy, Business, Finance

Full Data

?
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on the Chinese Stock Markets

Join Now!

Need this critical market data?

Access thousands of market events, data points, and news articles!

Already have an account?
Login

Home » News » ST Muyao (600671): Special Explanation of the Board of Directors of Hangzhou Tianmushan Pharmaceutical Co., Ltd. on the Internal Control Audit Report Issued by the Accounting Firm CFi.CN Zhongcai.com